Cellular vulnerability in brain aging and Alzheimer's disease - Clinical correlates and molecular background

被引:0
|
作者
Giannakopoulos, P
Gold, G
Michel, JP
Bouras, C
机构
[1] Univ Geneva, Sch Med, Dept Psychiat, HUG Belle Idee, CH-1225 Geneva, Switzerland
[2] Univ Geneva, Sch Med, Dept Geriatr, HUG Belle Idee, CH-1225 Geneva, Switzerland
来源
ANNALES DE MEDECINE INTERNE | 1998年 / 149卷 / 04期
关键词
Alzheimer; brain aging; centenarians; neuropathology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neuropathological changes associated with normal brain aging and Alzheimer's disease involve specific cortical circuits. Extensive hippocampal alterations are correlated with age-associated memory impairment, while substantial neurofibriliary tangle formation in neocortical association areas of the temporal lobe is a prerequisite for the development of Alzheimer's disease. Several lines of evidence indicate that there is no correlation between senile plaque densities and the degree of dementia in this disorder. The cortical involvement in the ninth and tenth decades of life is different from that observed in younger patients in that parietal and cingulate areas are affected early in the course of Alzheimer's disease, and neocortical senile plaques densities are strongly correlated with the severity of dementia. Moreover, Alzheimer's disease pathology is characterized in these very old patients by high neurofibrillary tangle densities in the anterior CA1 field, but not in the entorhinal cortex and inferior temporal cortex. These patterns of lesion distribution are discussed in respect to the neurochemical, genetic and metabolic factors which may influence the neuronal vulnerability in Alzheimer's disease.
引用
收藏
页码:187 / 191
页数:5
相关论文
共 50 条
  • [41] Clinical correlates of apolipoprotein E in Alzheimer's disease
    Frisoni, GB
    Bianchetti, A
    Govoni, S
    Trabucchi, M
    ANNALS OF NEUROLOGY, 1996, 40 (04) : 688 - 689
  • [42] Clinical correlates of apathy in patients with Alzheimer's disease
    Cobanoglu, E.
    Ozel-Kizil, E.
    Kirici, S.
    Bal, N.
    Alici, Y. Hosgoren
    Yucel, O.
    Bilgin, B.
    Turan, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S582 - S582
  • [43] Biological correlates to clinical subgroups of Alzheimer's disease
    Sjogren, M
    Wikkelso, C
    Wallin, A
    Blennow, K
    NEUROBIOLOGY OF AGING, 2004, 25 (02) : 251 - 251
  • [44] Biological correlates of clinical subgroups of Alzheimer's disease
    Sjögren, M
    Wikkelsö, C
    Östling, S
    Wallin, A
    Blennow, K
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (04) : 191 - 197
  • [45] Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease
    Surmeier, D. James
    Guzman, Jaime N.
    Sanchez-Padilla, Javier
    CELL CALCIUM, 2010, 47 (02) : 175 - 182
  • [46] NSAIDs and brain corticosteroid levels in brain aging and Alzheimer's disease
    Quinn, JF
    Montine, T
    Kaye, J
    Raber, J
    NEUROLOGY, 2005, 64 (06) : A102 - A102
  • [47] Molecular and cellular pathophysiology of preclinical Alzheimer's disease
    Mufson, Elliott J.
    Ikonomovic, Milos D.
    Counts, Scott E.
    Perez, Sylvia E.
    Malek-Ahmadi, Michael
    Scheff, Stephen W.
    Ginsberg, Stephen D.
    BEHAVIOURAL BRAIN RESEARCH, 2016, 311 : 54 - 69
  • [48] Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease
    Jeong, Sangyun
    MOLECULES AND CELLS, 2017, 40 (09) : 613 - 620
  • [49] Models of Alzheimer's disease: cellular and molecular aspects
    Hoyer, S
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1997, (49): : 11 - 21
  • [50] Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms
    Kerr, Jesse S.
    Adriaanse, Bryan A.
    Greig, Nigel H.
    Mattson, Mark P.
    Cader, M. Zameel
    Bohr, Vilhelm A.
    Fang, Evandro F.
    TRENDS IN NEUROSCIENCES, 2017, 40 (03) : 151 - 166